Keensight Capital to acquire Inke from Neuraxpharm
Inke is an inhalation active pharmaceutical ingredients (APIs) developer and manufacturer.
28 April 2023•1 min read
Inke is an inhalation active pharmaceutical ingredients (APIs) developer and manufacturer.
Apollo funds complete minority investment in Alpine-backed Apex Service Partners
17 hours ago · 2 mins read
Rainier Partners invests in Texas auto insurance MGA platform Apex
23 hours ago · 2 mins read
Stonepeak completes carve-out of BMO’s transportation and vendor finance units
23 hours ago · 2 mins read
Trivest-backed Wheelhouse buys California and Utah garage door firm All Star
23 hours ago · 1 min read
Water Street and JLL Partners’ Eversana announces acquisition of London’s Estima Scientific
30 October 2026 · 1 min read
DPE’s Mehler Systems to acquire majority stake in Bulgaria’s MARS Armor
30 October 2026 · 1 min read
Speyside Equity buys Midwest steel tubing and building products maker Tapco
29 October 2026 · 2 mins read
